Addressing drug resistance in cancer with macromolecular chemotherapeutic agents

NH Park, W Cheng, F Lai, C Yang… - Journal of the …, 2018 - ACS Publications
Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment
regimens. To circumvent resistance issues, we have designed a new class of …
被引用次数：120 相关文章

[引用][C] Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents

NH Park, W Cheng, F Lai, C Yang… - Journal of the American …, 2018 - cir.nii.ac.jp
Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents.

NH Park, W Cheng, F Lai, C Yang… - Journal of the …, 2018 - europepmc.org
Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment
regimens. To circumvent resistance issues, we have designed a new class of …

Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents

NH Park, W Cheng, F Lai, C Yang, PF De Sessions… - JACS, 2018 - research.ibm.com
Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment
regimens. To circumvent resistance issues, we have designed a new class of …

Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents

NH Park, W Cheng, F Lai, C Yang… - Journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment
regimens. To circumvent resistance issues, we have designed a new class of …

[引用][C] Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents

NH Park, W Cheng, F Lai, C Yang, PF de Sessions… - 2018